Technology
Health
Medical

Avinger

$0.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.015 (-3.19%) Today
-$0.005 (-1.10%) After Hours

Why Robinhood?

You can buy or sell Avinger and other stocks, options, ETFs, and crypto commission-free!

About

Avinger, Inc. Common Stock, also called Avinger, is a commercial-stage medical device company. Read More The firm designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. It offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.

Employees
75
Headquarters
Redwood City, California
Founded
2007
Market Cap
27.32M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.31M
High Today
$0.47
Low Today
$0.455
Open Price
$0.455
Volume
331.04K
52 Week High
$2.04
52 Week Low
$0.18

Collections

Technology
Health
Medical
2015 IPO
US
North America

News

Seeking AlphaMay 9

Avinger, Inc. (AVGR) CEO Jeff Soinski on Q1 2019 Results - Earnings Call Transcript

Avinger, Inc. (NASDAQ:AVGR) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Matt Kreps - Investor Relations, Darrow & Associates Jeff Soinski - CEO Mark Weinswig - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good day, ladies and welcome to your Avinger First Quarter 2019 Results Call. All lines have been in a listen-only mode and the floor will be opened for your questions and comments following the presentation. [Operator Instructions] ...

1,522
NasdaqMay 8

Avinger Provides First Quarter 2019 Shareholder Update

Pantheris Revenue Increases 46% over Prior Year REDWOOD CITY, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today reported results for the first quarter ended March 31, 2019. First Quarter and Recent Highlights Achieved revenue of $1.8 million for the first quarter of 2019, reflect...

715
Yahoo FinanceMay 8

Avinger, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 8, 2019 / Avinger, Inc. (NASDAQ: AVGR) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-B96C7411E49F7 To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile. About Investor Network Investor...

806

Earnings

-$10.40
-$6.93
-$3.47
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 12, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.